Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Business Segments

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoY
SimplifiedDetailed
FY'25FY'24FY'23FY'22
Revenue by Geography
CN$3.18M-26.6%$4.34M-3.7%$4.51M-4.1%$4.7M-22.0%
FR$35.28M+76.9%$19.95M+325%$4.7M-37.0%$7.46M-37.2%
US$681.42M-3.7%$707.68M+11.4%$635.19M+30.5%$486.83M+15.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Amphastar Pharmaceuticals break its business down?
Amphastar Pharmaceuticals (AMPH) reports revenue by business across 2 parts — Finished Pharmaceutical Products and Pharmaceutical Products. Each is extracted from the segment footnotes and tracked over time.
Where does Amphastar Pharmaceuticals's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Amphastar Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.